Time to all-cause death or repeated revascularization shorter with off-pump versus on-pump coronary artery bypass grafting
THURSDAY, March 10, 2022 (HealthDay News) — Coronary artery bypass grafting (CABG) outcomes are similar at 10 years for veterans undergoing “on-pump” or “off-pump” procedures, according to a study published online Feb. 16 in JAMA Surgery.
Jacquelyn A. Quin, M.D., from the Veterans Affairs Boston Healthcare System in West Roxbury, Massachusetts, and colleagues evaluated the 10-year outcomes and costs of off-pump versus on-pump CABG. The analysis included 2,203 veterans randomly assigned to the off-pump group (1,104 patients) or the on-pump group (1,099 patients).
The researchers found that the 10-year death rates were 34.2 percent for the off-pump group and 31.1 percent for the on-pump group (relative risk, 1.05; 95 percent confidence interval, 0.99 to 1.11; P = 0.12). For the off-pump group, the median time to the composite end point (all-cause death or repeated revascularization) was 4.6 years, which was approximately 4.3 months shorter than that for the on-pump group (5.0 years). There were no significant 10-year treatment-related differences for any other primary or secondary end points.
“For veterans, in the absence of contraindications, the traditional on-pump CABG technique should not be supplanted by an off-pump CABG approach,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
Cancer Survivors Have Lower Levels of Physical Activity
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Childhood Cancer Survivors Often Have Mental Distress in Adulthood
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer